Finally, in the independent RNA-seq validation cohort of 98 patients with DLBCL, the prognostic relevance of MAPK10 and CCL18 expression was evaluated using Kaplan–Meier survival analysis (Figure 5). This evidence concerns the gene CCL18 and diffuse large B-cell lymphoma.